Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-11
DOI
10.1038/s41467-020-18465-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuraminidase antigenic drift of H3N2 clade 3c.2a viruses alters virus replication, enzymatic activity and inhibitory antibody binding
- (2020) Harrison Powell et al. PLoS Pathogens
- Earliest infections predict the age distribution of seasonal influenza A cases
- (2020) Philip Arevalo et al. eLife
- Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019
- (2019) Joshua D. Doyle et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017–2018 Influenza Season
- (2019) Min Z Levine et al. JOURNAL OF INFECTIOUS DISEASES
- Effects of Influenza Vaccination in the United States during the 2017–2018 Influenza Season
- (2019) Melissa A Rolfes et al. CLINICAL INFECTIOUS DISEASES
- The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain
- (2019) Hongquan Wan et al. Nature Microbiology
- H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation
- (2018) James D. Allen et al. Human Vaccines & Immunotherapeutics
- Update: Influenza Activity in the United States During the 2017–18 Season and Composition of the 2018–19 Influenza Vaccine
- (2018) Rebecca Garten et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Influenza Vaccine Effectiveness in the United States during the 2016–2017 Season
- (2018) Brendan Flannery et al. CLINICAL INFECTIOUS DISEASES
- GISAID: Global initiative on sharing all influenza data – from vision to reality
- (2017) Yuelong Shu et al. Eurosurveillance
- Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
- (2017) Seth J. Zost et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting
- (2016) Katelyn M. Gostic et al. SCIENCE
- nextflu: real-time tracking of seasonal influenza virus evolution in humans
- (2015) Richard A. Neher et al. BIOINFORMATICS
- Preexisting human antibodies neutralize recently emerged H7N9 influenza strains
- (2015) Carole J. Henry Dunand et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014–2015 Influenza Season
- (2015) Benjamin S. Chambers et al. Cell Reports
- An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera
- (2014) Laura Couzens et al. JOURNAL OF VIROLOGICAL METHODS
- Antibody landscapes after influenza virus infection or vaccination
- (2014) J. M. Fonville et al. SCIENCE
- Factors associated with influenza vaccine receipt in community dwelling adults and their children
- (2014) Ryan Malosh et al. VACCINE
- In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen
- (2014) Teddy Wohlbold et al. Viruses-Basel
- Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands
- (2011) R. Bodewes et al. Clinical and Vaccine Immunology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started